Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Is using inhaled corticosteroid effective against COVID-19 pneumonia severity and mortality?
Kiliç H, Argüder E, Civak M, Gemcioğlu E, Kaya Kalem A, Hasanoğlu İ, Kayaaslan B, Günay S, Akpinar E, Hezer H, Şeref Parlak EŞ, Sadi Aykan F, Kocaman Y, Ünsay Metan E, Er M, Dalkiran A, Çelenk Ergüden H, Hancioğlu Z, Altin E, Ceylan E, Eser F, Altunsoy Aypak A, Akinci E, Karaahmetoğlu S, Asfuroğlu Kalkan E, Inan O, Yilmaz A, Yüksel Güler B, Çopuroğlu E, Özkoçak Turan I, Demir E, Hayme S, Gökmen D, Surel AA, Ünsal E, Hasanoğlu HC, Ateş İ, Güner R, Karalezli A. Kiliç H, et al. Among authors: er m. Tuberk Toraks. 2024 Sep;72(3):219-228. doi: 10.5578/tt.202403934. Tuberk Toraks. 2024. PMID: 39275934 Free article. English.
Effect of chronic lung diseases on mortality of prevariant COVID-19 pneumonia patients.
Kilic H, Arguder E, Karalezli A, Unsal E, Guner R, Kayaslan B, Hasanoglu İ, Ates İ, Civak M, Akpınar E, Parlak E, Sadi F, Kocaman Y, Günay S, Metan E, Er M, Dalkıran A, Hezer H, Ergüden H, Hancıoğlu Z, Kalem A, Eser F, Aypak A, Akıncı E, Karahmetoğlu S, Gemcioglu E, Kalkan E, İnan O, Yilmaz A, Güler B, Çopuroğlu E, Turan İ, Gökmen D, Hayme S, Surel AA. Kilic H, et al. Among authors: er m. Front Med (Lausanne). 2022 Oct 13;9:957598. doi: 10.3389/fmed.2022.957598. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36314036 Free PMC article.
Risk factors for the development of interstitial lung disease following severe COVID-19 pneumonia and outcomes of systemic corticosteroid therapy: 3-month follow-up.
Günay S, Parlak IS, Hezer H, Şeref Parlak EŞ, Umut MS, Hancıoğlu Z, Çelenk Ergüden H, Kocaman Y, Dalkıran A, Sertçelik Ü, Şerifoğlu İ, Akpınar E, Göktaş MF, Fidan M, Babahanoğlu B, Cander FS, Çıvgın E, Er M, Kılıç H, Argüder E, Tuğ T, Ünsal E, Hasanoğlu C, Günay İ, Babayiğit M, Ağca B, Karalezli A. Günay S, et al. Among authors: er m. Sarcoidosis Vasc Diffuse Lung Dis. 2023 Sep 13;40(3):e2023029. doi: 10.36141/svdld.v40i3.14418. Sarcoidosis Vasc Diffuse Lung Dis. 2023. PMID: 37712369 Free PMC article.
Endobronchial hamartoma.
Yildirim BB, Karalezli A, Er M, Balkan E, Kandemir O, Hasanoglu HC. Yildirim BB, et al. Among authors: er m. J Bronchology Interv Pulmonol. 2011 Oct;18(4):355-8. doi: 10.1097/LBR.0b013e318232ff0e. J Bronchology Interv Pulmonol. 2011. PMID: 23208633
145 results